These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20584752)

  • 1. OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization.
    Nakano M; Fukumoto Y; Satoh K; Ito Y; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
    Cardiovasc Res; 2010 Dec; 88(3):539-46. PubMed ID: 20584752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
    van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
    Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT
    Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic change OX40/OX40L mRNA in experimental allergic neuritis].
    Zhang N; Li G; Xiao B; Liu Y; Cai Y; Sun X; Liang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):964-8. PubMed ID: 20871162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice.
    Veerman KJ; Venegas-Pino DE; Shi Y; Khan MI; Gerstein HC; Werstuck GH
    Atherosclerosis; 2013 Apr; 227(2):250-8. PubMed ID: 23411040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cell-selective adhesion molecule modulates atherosclerosis through plaque angiogenesis and monocyte-endothelial interaction.
    Inoue M; Ishida T; Yasuda T; Toh R; Hara T; Cangara HM; Rikitake Y; Taira K; Sun L; Kundu RK; Quertermous T; Hirata K
    Microvasc Res; 2010 Sep; 80(2):179-87. PubMed ID: 20406651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasa vasorum and atherosclerosis - Quid novi?
    Langheinrich AC; Kampschulte M; Buch T; Bohle RM
    Thromb Haemost; 2007 Jun; 97(6):873-9. PubMed ID: 17549287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the costimulatory molecules OX40-OX40 ligand interaction on the expression of NFATc1 in leukocytes of apolipoprotein E-deficient mice].
    Xu LJ; Yan JC; Wang B; Liu PJ; Gong J; Wang CP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun; 39(6):526-30. PubMed ID: 21924079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
    Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
    Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
    al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
    Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.
    Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J
    J Immunol; 2013 Nov; 191(9):4573-80. PubMed ID: 24068673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
    Mendel I; Shevach EM
    Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
    Soroosh P; Ine S; Sugamura K; Ishii N
    J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40-OX40 ligand interaction may activate phospholipase C signal transduction pathway in human umbilical vein endothelial cells.
    Yan J; Wang C; Du R; Liu P; Chen G
    Chem Biol Interact; 2009 Aug; 180(3):460-4. PubMed ID: 19416722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting vasa vasorum dysfunction to prevent atherosclerosis.
    Boyle EC; Sedding DG; Haverich A
    Vascul Pharmacol; 2017 Sep; 96-98():5-10. PubMed ID: 28830735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
    Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
    Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.